Institut für Klinische Neurobiologie
Refine
Has Fulltext
- yes (157)
Is part of the Bibliography
- yes (157)
Year of publication
Document Type
- Journal article (103)
- Doctoral Thesis (47)
- Preprint (2)
- Report (2)
- Review (2)
- Book article / Book chapter (1)
Keywords
- Motoneuron (16)
- Spinale Muskelatrophie (11)
- BDNF (9)
- glycine receptor (9)
- spinal muscular atrophy (6)
- Actin (5)
- CNTF (5)
- SMN (5)
- hyperekplexia (5)
- motoneurons (5)
- neurons (5)
- startle disease (5)
- Ionenkanal (4)
- Maus (4)
- Nervenzelle (4)
- TrkB (4)
- Zellkultur (4)
- Axon (3)
- Ciliary neurotrophic factor (3)
- Entzündung (3)
- Glycin (3)
- Glycinrezeptor (3)
- Hippocampus (3)
- Hyperekplexie (3)
- Phospholipide (3)
- SMA (3)
- STAT3 (3)
- Spinal Muscular Atrophy (3)
- Stathmin (3)
- amyotrophic lateral sclerosis (3)
- ciliary neurotrophic factor (3)
- hippocampus (3)
- motoneuron (3)
- neurology (3)
- neuromuscular junction (3)
- synaptic vesicles (3)
- 3D cell culture (2)
- Apoptosis (2)
- BDNF stimulation (2)
- Bewegungsstörung (2)
- Cell culture (2)
- Cys-loop receptor (2)
- Drosophila melanogaster (2)
- Genexpression (2)
- Microtubules (2)
- Motoneuronenerkrankung (2)
- Myatrophische Lateralsklerose (2)
- NaV1.9 (2)
- Neurobiologie (2)
- Neurotrophic factors (2)
- Nociceptor (2)
- PLEKHG5 (2)
- RNA (2)
- Ribosom (2)
- Sap47 (2)
- Schmerzforschung (2)
- Schmerztherapie (2)
- Signaltransduktion (2)
- Spinal muscular atrophy (2)
- Stat3 (2)
- Synapse (2)
- Taufliege (2)
- Transcription (2)
- autoantibodies (2)
- autophagy (2)
- axons (2)
- binding (2)
- cAMP (2)
- cerebellum (2)
- cortical neurons (2)
- drosophila melanogaster (2)
- fear (2)
- glycine receptor autoantibodies (2)
- glycine uptake (2)
- growth cone (2)
- hnRNP R (2)
- hnRNP-R (2)
- hybridomas (2)
- immunoprecipitation (2)
- intracellular domain (2)
- ion channel (2)
- loss of function (2)
- melt electrowriting (2)
- motoneuron disease (2)
- mouse (2)
- mushroom body (2)
- neurofascin (2)
- neuropathic pain (2)
- neurotrophins (2)
- pain (2)
- phosphorylation (2)
- pmn (2)
- prefrontal cortex (2)
- presynaptic hyperekplexia (2)
- receptor (2)
- spinal cord (2)
- structural disruption (2)
- synaptic inhibition (2)
- synaptic plasticity (2)
- trkB (2)
- 2-pore potassium channel (1)
- 3D cell cultures (1)
- 3D cultures (1)
- 3D electrophysiology (1)
- 3D microfiber (1)
- 3D model systems (1)
- 3D muscle (1)
- 3D neuronal networks (1)
- 3D tumor model (1)
- 3D-Zellkultur (1)
- 4-HNE (1)
- 7,8-dihydroxyflavone (7,8-DHF) (1)
- 7SK (1)
- ALS (1)
- AMPA (1)
- ASC-1 (1)
- Actin Dynamics (1)
- Aging (1)
- Alpha-synuclein oligomers (1)
- Alzheimer disease (1)
- Alzheimer's disease (1)
- Alzheimers disease (1)
- Alzheimer’s disease (1)
- Aminobuttersäure <gamma-> (1)
- Aminosäuren (1)
- Amyloid-beta oligomers; (1)
- Amyotrophe Lateralsklerose (1)
- Amyotrophic lateral sclerosis (1)
- Amyotrophic-lateral-sclerosis (1)
- Animal modell (1)
- ApoA-I D-4F (1)
- Asc-1 transporter (1)
- Associative learning (1)
- Astrocytes ; Schwann cells ; Interferon-gamma ; Fibroblast growth factor ; Cyclic AMP (1)
- Autism spectrum disorders (1)
- Autoantikörper (1)
- Axon Branching (1)
- Axon degeneration (1)
- Axon growth (1)
- Axonal transport (1)
- Axonaler Transport (1)
- BNDF (1)
- BSTA (1)
- Bag1 (1)
- Bildanalyse (1)
- Biologie (1)
- Brain (1)
- Brain-derived neurotrophic factor (1)
- C. elegans (1)
- C9orf72 (1)
- CNS (1)
- CNTF Sehnerv Retina Degeneration (1)
- CNTF optic nerve retina degeneration (1)
- COVID-19 (1)
- Ca\(^{2+}\)-Imaging (1)
- Ca\(_{v}\)2.2 (1)
- Calcium Imaging (1)
- Caspr2 (1)
- Cav2.2 (1)
- Cells (1)
- Cellular prion protein (1)
- Central nervous system (1)
- Chaperone (1)
- Chaperones (1)
- Co-culture (1)
- Contactin-assoziiertes Protein 2 (1)
- Cytochrom C (1)
- Cytochrom c (1)
- Cytochrome C (1)
- Cytokine (1)
- Cytokines (1)
- DAPI staining (1)
- DNA damage (1)
- DNA repeat expansion (1)
- DRD1 (1)
- DRG (1)
- Deeplearning (1)
- Dentate granule cells (1)
- Diabetic polyneuropathy (1)
- Diabetische Polyneuropathie (1)
- Dorsal root ganglion (1)
- Down syndrome (1)
- Drosophilia (1)
- Dynamics of ribosome assembly (1)
- E06 mAb (1)
- EAE (1)
- EGFR (1)
- ER dynamics in axon terminals (1)
- Embryonalentwicklung (1)
- Endoplasmatisches Retikulum (1)
- Erregbarkeit (1)
- Exercise (1)
- F-actin (1)
- FGF-5 (1)
- Facial Nerve Transection (1)
- Familial Alzheimers-disease (1)
- Fazialisläsion (1)
- Fear conditioning (1)
- Fibroblast Growth Factor (1)
- Funktionsverlust (1)
- GABA receptor (1)
- GABA-A receptor (1)
- GABA-Rezeptor (1)
- GABA\(_{A}\) (1)
- GABA\(_{A}\) receptor (1)
- GDNF (1)
- GPCR (1)
- Gedächtnis (1)
- Geruch (1)
- Glucocorticosteroide (1)
- Glutamatergic synapses (1)
- GlyR receptors (1)
- GlyRs (1)
- Glycintransporter 2 (GlyT2) (1)
- Golgi apparatus (1)
- Golgi-Apparat (1)
- Großhirnrinde (1)
- Guillain-Barre-Syndrome (1)
- H2O2 (1)
- Heterogene Ribonucleoproteine (1)
- Histon-Deacetylase (1)
- ICAM-1 (1)
- IGF-I (1)
- IGF1 (1)
- IgG4 (1)
- Ighmbp2 (1)
- Immunhistochemie (1)
- Immunoblot (1)
- Immunopanning (1)
- Induced pluripotent stem cells (1)
- Induzierte pluripotente Stammzelle (1)
- Inflammatory Pain (1)
- Inhibitorische Synapse (1)
- Inhibitory glycine receptor (1)
- Insulin-like Growth (1)
- Insulin-like-Growth-Factor-Binding-Protein-5 (1)
- Insulinlike Growth Factor (1)
- Integrated Defensive States (1)
- Interaction of 7SK with the Smn complex modulates snRNP production (1)
- Intermediate filaments (1)
- Isomer (1)
- JNK (1)
- Kalyx (1)
- Kalziumkanalagonisten (1)
- Kenyon cells (1)
- Kinasen (1)
- Knockdown (1)
- Knockout (1)
- Konformationsänderung (1)
- Kortikogenese (1)
- Krankheit (1)
- LIFR (1)
- LTP (1)
- Lacking neurofilaments (1)
- Laminin (1)
- Learning and memory (1)
- Lernen (1)
- Lysosomal storage disease (1)
- MAP1B (1)
- MND (1)
- MOC fibers (1)
- Mausmodell (1)
- Migration (1)
- Missense mutation (1)
- Molecular neuroscience (1)
- Morpholino (1)
- Motoneuron disease (1)
- Motoneuron-Krankheit (1)
- Motoneuronenerkrankungen (1)
- Motoneuronerkrankung (1)
- Motoneurons (1)
- Motor behaviour (1)
- Motor neuron disease (1)
- Motor neuron disease; Ciliary neurotrophic factor; Brain-derived neurotrophic factor; Animal models; Neurotrophic factors (1)
- Motorische Endplatte (1)
- Mouse model (1)
- Mus spretus (1)
- N-Typ Kalziumkanäle (1)
- N-type calcium channel (1)
- NGF gene family (1)
- NMDAR (1)
- NMJ (neuromuscular junction) (1)
- NMJ–neuromuscular junction (1)
- NTRK fusions (1)
- Natriumkanal (1)
- Nervennetz (1)
- Nervensystem (1)
- Neural Stem Cells (1)
- Neural circuits (1)
- Neurale Stammzellen (1)
- Neuritenwachstum (1)
- Neurodegeneration (1)
- Neurofilament (1)
- Neurogenese (1)
- Neuromuskuläre Endplatte (1)
- Neuronal ceroid lipofuscinosis (1)
- Neuronale Differenzierung (1)
- Neuronale Plastizität (1)
- Neurotropher Faktor (1)
- Neurotrophin (1)
- Neurotrophine (1)
- Object recognition (1)
- Optical coherence tomography (1)
- Oxidized Phospholipids (1)
- P75 Neurotrophin receptor (1)
- PAG (1)
- PDXP inhibitors (1)
- PKB/Akt phosphorylation (1)
- PTEN (1)
- Parkinson’s disease (1)
- Pathologie (1)
- Perianova, Irina (1)
- Periaqueductal gray (1)
- Phosphorylation (1)
- Pilzkörper (1)
- Plasma-membrane (1)
- Pleckstrin homology containing family member 5 (Plekhg5) (1)
- Progressive motor neuronopathy (1)
- Protein kinase B (1)
- Proteine (1)
- Proteintransport (1)
- Präsynaptische Hyperekplexie (1)
- R-Roscovitine (1)
- RHO (1)
- RNA splicing (1)
- RNA transport (1)
- RNA-binding proteins (1)
- ROCK (1)
- RSK2 (1)
- Raf (1)
- Raf <Biochemie> (1)
- Raf Kinasen (1)
- Raf Kinases (1)
- Raf-Kinase (1)
- Raf-Kinasen (1)
- Reprogrammming (1)
- Retinal degeneration (1)
- Rezeptor (1)
- Rictor-mTOR complex (1)
- Roscovitine (1)
- SAP47 gene (1)
- SARS-CoV- 2 (1)
- SLC6A5 (1)
- SLC7A10 (1)
- SMARD1 (1)
- SMN granules (1)
- SOD1 (1)
- SPAQ (1)
- STAT (1)
- Satellite glial cell (1)
- Schmerz (1)
- Schwann cells (1)
- Sehnerv (1)
- Small fiber Neuropathie (1)
- Small fiber neuropathy (1)
- Smn (1)
- Spinal Muscular-arthropy (1)
- Spinal muscular atrophy (DLC) (1)
- Spinale Muskelathropie (1)
- Spinalganglion (1)
- Spliceosome (1)
- Stammzellen (1)
- Syap1 (1)
- Syap1 knockout (1)
- Syap1 localization (1)
- Synapse-associated protein (1)
- Synapsen assoziiert (1)
- Synaptische Transmission (1)
- T-cadherin (1)
- TBCE (1)
- TRP channel (1)
- TRPA1 (1)
- TRPA1 channel (1)
- Temporal-lobe epilepsy (1)
- Tiermodell (1)
- Tissue Engineering (1)
- Transgenic mice (1)
- Ultraschall (1)
- VCAM-1 (1)
- Valproat (1)
- Valproic acid (1)
- Valproinsäure (1)
- Vascular plasticity (1)
- Viability (1)
- Wachstum (1)
- YB-1 (1)
- Yb1 (1)
- Zelldifferenzierung (1)
- Zentrales Nervensystem (1)
- Zytokine (1)
- actin (1)
- actin messenger RNA (1)
- activation (1)
- adenocarcinoma of the lung (1)
- adsorption (1)
- allosteric modulation (1)
- alpha-7 nicotinic acetylcholine receptor (1)
- amoeboid cell migration (1)
- amygdala (1)
- analgesia (1)
- antibodies (1)
- antigen processing and recognition (1)
- anxiety (1)
- apoptosis (1)
- astrocytes (1)
- autism (1)
- autoantibody (aAb) (1)
- autoimmune antibodies (1)
- autoimmune nodopathy (1)
- axon (1)
- axon growth (1)
- axonal transport (1)
- axonaler Transport (1)
- barrier (1)
- basal ganglia (1)
- behavioral disorders (1)
- beta-actin (1)
- bioimage analysis (1)
- biopsies (1)
- brain (1)
- brain cancer (1)
- breast cancer (1)
- c-Jun (1)
- cadherin-13 (CDH13) (1)
- calcium activity (1)
- calcium channels (1)
- calyx (1)
- cancer (1)
- candidate gene (1)
- cardiology (1)
- cell death (1)
- cell staining (1)
- cells (1)
- cerebral blood flow (1)
- channel (1)
- chick (1)
- choline acetyltransferase (1)
- chronic pain (1)
- ciliary neuron (1)
- ciliary-neurotrophic factor (1)
- circuits and circuit components (1)
- claudin-5 (1)
- click-chemistry (1)
- clinical neurology (1)
- cochlea (1)
- comet assay (1)
- compartimentalized cultures (1)
- contactin (1)
- cortico-striatal synapse (1)
- corticogenesis (1)
- cross-sectional studies (1)
- cytosol (1)
- dSPN (1)
- dSTORM (1)
- deep brain stimulation (1)
- defensive states (1)
- degeneration (1)
- demyelination (1)
- dendrite (1)
- dentate gyrus (1)
- determining gene-product (1)
- direct pathway (1)
- domain (1)
- domain K\(^{+}\) channels (1)
- dominant (1)
- dorsal raphe (1)
- dorsal root ganglion (1)
- durotaxis (1)
- dynamics of ribosomal assembly (1)
- early-onset predictors (1)
- electron tomography (1)
- embryos (1)
- emotional states (1)
- energy metabolism (1)
- enrichment (1)
- epilepsy (1)
- exercise (1)
- extracellular domain (1)
- facial nerve lesion (1)
- factor prevents (1)
- fast decay (1)
- fluorescence in-situ hybridization (1)
- frontotemporal dementia (1)
- fused in sarcoma (1)
- gait (1)
- gel electrophoresis (1)
- gene expression (1)
- gene targeting (1)
- genetic code expansion (1)
- genome wide (1)
- gephyrin (1)
- glycine receptor (GlyR) (1)
- glycine transporter 2 (1)
- glycogen phosphorylase (1)
- glycogen synthase (1)
- glycolysis (1)
- glycosylation (1)
- glyvine uptake (1)
- granule cells (1)
- hearing loss (1)
- heart rate (1)
- hippocampal neurons (1)
- hnRNP (1)
- hnRNP-Q (1)
- homologous recombination (1)
- human startle disease (1)
- hyaluronic acid (1)
- iPSC (induced pluripotent stem cells) (1)
- immune response (1)
- immune serum (1)
- immunocytochemical analysis (1)
- immunohistochemical (1)
- immunohistochemistry techniques (1)
- inflammatory demyelinating polyradiculoneuropathy (1)
- inflammatory neuropathy (1)
- inflammatory pain (1)
- inhibitory snapse (1)
- initiation (1)
- injury (1)
- insulin (1)
- insulin-likegrowth factor I (1)
- interaction partners (1)
- interacts (1)
- interleukin 6 (1)
- interspeific backcross (1)
- intrazelluläre Domäne (1)
- ion channels in the nervous system (1)
- knockout mice (1)
- kompartimentierte Kulturen (1)
- lIF (1)
- larval drosophila (1)
- library screening (1)
- ligand potencies (1)
- linalool (1)
- linalyl acetate (1)
- linkage (1)
- lithium (1)
- local protein synthesis (1)
- locomotion (1)
- loop B (1)
- lung and intrathoracic tumors (1)
- mRNA localization (1)
- machine learning (1)
- macrophages (1)
- mechanisms (1)
- medicine (1)
- memory (1)
- mesencephalic locomotor region (1)
- metastasis (1)
- microscopy (1)
- microtubules (1)
- migraine (1)
- migration (1)
- mild cognitive impairment (1)
- mimetic peptide (1)
- modulation (1)
- molecular mechanisms (1)
- molecular medicine (1)
- molecular neuroscience (1)
- monoclonal antibodies (1)
- morpholino knockdown (1)
- motoneuron (MN) (1)
- motor axon (1)
- motor axons (1)
- motor control (1)
- motor learning (1)
- motor neuron (1)
- motor neuron degeneration (1)
- motor neurons (1)
- motor neuropathy (1)
- mouse model (1)
- movement disorders (1)
- mulitple-sclerosis patients (1)
- musk myasthenia gravis (1)
- mutations (1)
- myelin (1)
- nerve injury (1)
- nerve lesion (1)
- nerve ultrasonography (1)
- nervous system (1)
- neural networks (1)
- neurite (1)
- neurodegeneration (1)
- neurodegenerative disorder (1)
- neurodevelopment (1)
- neurofilaments (1)
- neuroinflammation (1)
- neuron migration (1)
- neuronal dendrites (1)
- neuronal differentiation (1)
- neuronal excitability (1)
- neuronal network (1)
- neuronal networks (1)
- neuronal primary culture (1)
- neuronal survival and differentiation (1)
- neuronale Plastizität (1)
- neuropathy (1)
- neuropil (1)
- neuroscience (1)
- neurotrophe Faktoren (1)
- neurotrophic (1)
- neurotrophic factor (1)
- neurotrophic molecules (1)
- nifedipine (1)
- nociception (1)
- node of ranvier (1)
- non-small cell lung cancer (1)
- nonneuronaI cells (1)
- nuclear ribonucleoprotein-R (1)
- ontactin 1 (1)
- outer hair cell (OHC) (1)
- oxidized phospholipids (1)
- oxygenation (1)
- pain therapy (1)
- passive transfer (1)
- patch clamp recording (1)
- patch-clamp (1)
- pegylated insulin-like growth factor 1 (1)
- periperal nerve (1)
- peripheral neuropathy (1)
- phosphorylase isozymes (1)
- photothrombotic stroke (1)
- pmn-Maus (1)
- postsynaptic potentials (1)
- posttranslational modifications (1)
- prediction error (1)
- presynapse (1)
- presynaptic ER dynamics (1)
- primary notoneuron (1)
- primäre Motoneurone (1)
- programmed cell death (1)
- progressive encephalitis with rigidity and myoclonus (PERM) (1)
- protein coupled receptors (1)
- protein interactions (1)
- protein maturation (1)
- protein synthesis (1)
- protein transport (1)
- psychiatric disorders (1)
- pyridoxal phosphatase (PDXP) (1)
- quality control (1)
- radial glia (1)
- rat (1)
- recombinant proteins (1)
- regulation (1)
- rescue (1)
- restriction fragment length polymorphism (1)
- roles (1)
- secondary lung tumors (1)
- self-activation (1)
- sensory neurons (1)
- serotonin (1)
- shaky mouse (1)
- short-term memory (1)
- side chain properties (1)
- silver staining (1)
- site (1)
- skeletal muscle (1)
- snRNP (1)
- sodium channel (1)
- software (1)
- spastic (1)
- spinal cord neurons (1)
- spontaneous excitation (1)
- spontaneous mouse mutants (1)
- startle (1)
- startle reaction (1)
- stathmin (1)
- stiff person syndrome (1)
- stiff-person syndrome (SPS) (1)
- stroke (1)
- subcellular trafficking (1)
- super-resolution microscopy (SRM) (1)
- superficial peroneal nerve (1)
- sural nerve (1)
- survey (1)
- survival (1)
- switch (1)
- synapse structure (1)
- synapses (1)
- synaptic localization (1)
- synaptic proteins (1)
- synaptic transmission (1)
- synaptisches Protein (1)
- synthase (1)
- systems biology (1)
- telemedicine (1)
- therapeutic antibody (1)
- thoracic diaphragm (1)
- tight junction (1)
- topotaxis (1)
- trafficking (1)
- trafficking pathways (1)
- transactivation (1)
- transport (1)
- trophic/potassium deprivation (1)
- tyrosine kinase (1)
- ultrasound (1)
- uper-resolution array tomography (1)
- vasculitis (1)
- vector cloning (1)
- vitamin B6 (1)
- α-synuclein-specific T cells (1)
- β-Aktin (1)
- β-actin (1)
- β-actin mRNA (1)
- β8-β9 loop (1)
Institute
- Institut für Klinische Neurobiologie (157)
- Graduate School of Life Sciences (18)
- Neurologische Klinik und Poliklinik (16)
- Theodor-Boveri-Institut für Biowissenschaften (16)
- Rudolf-Virchow-Zentrum (8)
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (7)
- Abteilung für Funktionswerkstoffe der Medizin und der Zahnheilkunde (4)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (4)
- Institut für Anatomie und Zellbiologie (3)
- Betriebswirtschaftliches Institut (1)
High-resolution ultrasonography (HRUS) is an emerging new tool in the investigation of peripheral nerves. We set out to assess the utility of HRUS performed at lower extremity nerves in peripheral neuropathies. Nerves of 26 patients with polyneuropathies of different etiologies and 26 controls were investigated using HRUS. Patients underwent clinical, laboratory, electrophysiological assessment, and a diagnostic sural nerve biopsy as part of the routine work-up. HRUS was performed at the sural, tibial, and the common, superficial, and deep peroneal nerves. The superficial peroneal nerve longitudinal diameter (LD) distinguished best between the groups: patients with immune-mediated neuropathies (n = 13, including six with histology-proven vasculitic neuropathy) had larger LD compared to patients with non-immune-mediated neuropathies (p < 0.05) and to controls (p < 0.001). Among all subgroups, patients with vasculitic neuropathy showed the largest superficial peroneal nerve LD (p < 0.001) and had a larger sural nerve cross-sectional area when compared with disease controls (p < 0.001). Enlargement of the superficial peroneal and sural nerves as detected by HRUS may be a useful additional finding in the differential diagnosis of vasculitic and other immune-mediated neuropathies.
Neurofilament depletion improves microtubule dynamics via modulation of Stat3/stathmin signaling
(2016)
In neurons, microtubules form a dense array within axons, and the stability and function of this microtubule network is modulated by neurofilaments. Accumulation of neurofilaments has been observed in several forms of neurodegenerative diseases, but the mechanisms how elevated neurofilament levels destabilize axons are unknown so far. Here, we show that increased neurofilament expression in motor nerves of pmn mutant mice, a model of motoneuron disease, causes disturbed microtubule dynamics. The disease is caused by a point mutation in the tubulin-specific chaperone E (Tbce) gene, leading to an exchange of the most C-terminal amino acid tryptophan to glycine. As a consequence, the TBCE protein becomes instable which then results in destabilization of axonal microtubules and defects in axonal transport, in particular in motoneurons. Depletion of neurofilament increases the number and regrowth of microtubules in pmn mutant motoneurons and restores axon elongation. This effect is mediated by interaction of neurofilament with the stathmin complex. Accumulating neurofilaments associate with stathmin in axons of pmn mutant motoneurons. Depletion of neurofilament by Nefl knockout increases Stat3-stathmin interaction and stabilizes the microtubules in pmn mutant motoneurons. Consequently, counteracting enhanced neurofilament expression improves axonal maintenance and prolongs survival of pmn mutant mice. We propose that this mechanism could also be relevant for other neurodegenerative diseases in which neurofilament accumulation and loss of microtubules are prominent features.
Glycine receptor β–targeting autoantibodies contribute to the pathology of autoimmune diseases
(2024)
Background and Objectives
Stiff-person syndrome (SPS) and progressive encephalomyelitis with rigidity and myoclonus (PERM) are rare neurologic disorders of the CNS. Until now, exclusive GlyRα subunit–binding autoantibodies with subsequent changes in function and surface numbers were reported. GlyR autoantibodies have also been described in patients with focal epilepsy. Autoimmune reactivity against the GlyRβ subunits has not yet been shown. Autoantibodies against GlyRα1 target the large extracellular N-terminal domain. This domain shares a high degree of sequence homology with GlyRβ making it not unlikely that GlyRβ-specific autoantibody (aAb) exist and contribute to the disease pathology.
Methods
In this study, we investigated serum samples from 58 patients for aAb specifically detecting GlyRβ. Studies in microarray format, cell-based assays, and primary spinal cord neurons and spinal cord tissue immunohistochemistry were performed to determine specific GlyRβ binding and define aAb binding to distinct protein regions. Preadsorption approaches of aAbs using living cells and the purified extracellular receptor domain were further used. Finally, functional consequences for inhibitory neurotransmission upon GlyRβ aAb binding were resolved by whole-cell patch-clamp recordings.
Results
Among 58 samples investigated, cell-based assays, tissue analysis, and preadsorption approaches revealed 2 patients with high specificity for GlyRβ aAb. Quantitative protein cluster analysis demonstrated aAb binding to synaptic GlyRβ colocalized with the scaffold protein gephyrin independent of the presence of GlyRα1. At the functional level, binding of GlyRβ aAb from both patients to its target impair glycine efficacy.
Discussion
Our study establishes GlyRβ as novel target of aAb in patients with SPS/PERM. In contrast to exclusively GlyRα1-positive sera, which alter glycine potency, aAbs against GlyRβ impair receptor efficacy for the neurotransmitter glycine. Imaging and functional analyses showed that GlyRβ aAbs antagonize inhibitory neurotransmission by affecting receptor function rather than localization.
Background: Glioblastoma multiforme (GBM) and metastatic triple-negative breast cancer (TNBC) with PTEN mutations often lead to brain dissemination with poor patient outcome, thus new therapeutic targets are needed. To understand signaling, controlling the dynamics and mechanics of brain tumor cell migration, we implemented GBM and TNBC cell lines and designed 3D aligned microfibers and scaffolds mimicking brain structures. Methods: 3D microfibers and scaffolds were printed using melt electrowriting. GBM and TNBC cell lines with opposing PTEN genotypes were analyzed with RHO-ROCK-PTEN inhibitors and PTEN rescue using live-cell imaging. RNA-sequencing and qPCR of tumor cells in 3D with microfibers were performed, while scanning electron microscopy and confocal microscopy addressed cell morphology. Results: In contrast to the PTEN wildtype, GBM and TNBC cells with PTEN loss of function yielded enhanced durotaxis, topotaxis, adhesion, amoeboid migration on 3D microfibers and significant high RHOB expression. Functional studies concerning RHOB-ROCK-PTEN signaling confirmed the essential role for the above cellular processes. Conclusions: This study demonstrates a significant role of the PTEN genotype and RHOB expression for durotaxis, adhesion and migration dependent on 3D. GBM and TNBC cells with PTEN loss of function have an affinity for stiff brain structures promoting metastasis. 3D microfibers represent an important tool to model brain metastasizing tumor cells, where RHO-inhibitors could play an essential role for improved therapy.
Cell-autonomous axon growth of young motoneurons is triggered by a voltage-gated sodium channel
(2013)
Spontaneous electrical activity preceding synapse formation contributes to the precise regulation of neuronal development. Examining the origins of spontaneous activity revealed roles for neurotransmitters that depolarize neurons and activate ion channels. Recently, we identified a new molecular mechanism underlying fluctuations in spontaneous neuronal excitability. We found that embryonic motoneurons with a genetic loss of the low-threshold sodium channel Na\(_V\)1.9 show fewer fluctuations in intracellular calcium in axonal compartments and growth cones than wild-type littermates. As a consequence, axon growth of Na\(_V\)1.9-deficient motoneurons in cell culture is drastically reduced while dendritic growth and cell survival are not affected. Interestingly, Na\(_V\)1.9 function is observed under conditions that would hardly allow a ligand- or neurotransmitter-dependent depolarization. Thus, Na\(_V\)1.9 may serve as a cell-autonomous trigger for neuronal excitation. In this addendum, we discuss a model for the interplay between cell-autonomous local neuronal activity and local cytoskeleton dynamics in growth cone function.
Investigations into the Pathogenic Antibody-Antigen-Interference of Glycine Receptor Autoantibodies
(2021)
Anti-glycine receptor (GlyR) autoantibodies belong to the novel group of autoantibodies that target neuronal cell-surface antigens (NCS), which are accompanied with various neurologic and neuropsychiatric conditions. The inhibitory ionotropic GlyR is one of the major inhibitory neurotransmitter receptors and therefore involved in maintaining homeostasis of neuronal excitation levels at brain stem and spinal cord. Anti-GlyR autoantibodies are associated with progressive encephalomyelitis with rigidity and myoclonus or stiff person syndrome. These neuromotor disorders are characterized by exaggerated startle, muscle stiffness, and painful spasms, leading to immobility and fatal outcome in some cases. It was hypothesized that imbalance of motoneuronal inhibition by functional impairment of GlyR and receptor internalization are direct consequences of antibody-antigen interference. Here, serum samples of four patients were tested for anti-GlyR autoantibodies and were used for the analysis of the functional impact on the electrophysiological properties of recombinant GlyRs, transiently expressed in HEK293 cells. Furthermore, the recognition pattern of anti- GlyR autoantibodies to human, zebrafish and chimeric GlyRα1 located the epitope to the far N-terminal region. The pathogenicity of anti-GlyR autoantibodies and thereby the autoimmunologic etiology of the disease was confirmed by passive transfer of patient serum to zebrafish (Danio rerio) larvae, that yielded an abnormal escape response – a brain stem reflex that corresponds to the exaggerated startle of afflicted patients. The phenotype was accompanied by profound reduction of GlyR clusters in spinal cord cryosections of treated zebrafish larvae. Together, these novel insights into the pathogenicity of GlyR autoantibodies confirm the concept of a novel neurologic autoimmune disease and might contribute to the development of innovative therapeutic strategies.
Synapse-associated protein 1 (Syap1) is the mammalian homologue of synapse-associated protein of 47 kDa (Sap47) in Drosophila. Genetic deletion of Sap47 leads to deficiencies in short-term plasticity and associative memory processing in flies. In mice, Syap1 is prominently expressed in the nervous system, but its function is still unclear. We have generated Syap1 knockout mice and tested motor behaviour and memory. These mice are viable and fertile but display distinct deficiencies in motor behaviour. Locomotor activity specifically appears to be reduced in early phases when voluntary movement is initiated. On the rotarod, a more demanding motor test involving control by sensory feedback, Syap1-deficient mice dramatically fail to adapt to accelerated speed or to a change in rotation direction. Syap1 is highly expressed in cerebellar Purkinje cells and cerebellar nuclei. Thus, this distinct motor phenotype could be due to a so-far unknown function of Syap1 in cerebellar sensorimotor control. The observed motor defects are highly specific since other tests in the modified SHIRPA exam, as well as cognitive tasks like novel object recognition, Pavlovian fear conditioning, anxiety-like behaviour in open field dark-light transition and elevated plus maze do not appear to be affected in Syap1 knockout mice.
Background and purpose
The effects of the coronavirus disease 2019 (COVID-19) pandemic on telemedical care have not been described on a national level. Thus, we investigated the medical stroke treatment situation before, during, and after the first lockdown in Germany.
Methods
In this nationwide, multicenter study, data from 14 telemedical networks including 31 network centers and 155 spoke hospitals covering large parts of Germany were analyzed regarding patients' characteristics, stroke type/severity, and acute stroke treatment. A survey focusing on potential shortcomings of in-hospital and (telemedical) stroke care during the pandemic was conducted.
Results
Between January 2018 and June 2020, 67,033 telemedical consultations and 38,895 telemedical stroke consultations were conducted. A significant decline of telemedical (p < 0.001) and telemedical stroke consultations (p < 0.001) during the lockdown in March/April 2020 and a reciprocal increase after relaxation of COVID-19 measures in May/June 2020 were observed. Compared to 2018–2019, neither stroke patients' age (p = 0.38), gender (p = 0.44), nor severity of ischemic stroke (p = 0.32) differed in March/April 2020. Whereas the proportion of ischemic stroke patients for whom endovascular treatment (14.3% vs. 14.6%; p = 0.85) was recommended remained stable, there was a nonsignificant trend toward a lower proportion of recommendation of intravenous thrombolysis during the lockdown (19.0% vs. 22.1%; p = 0.052). Despite the majority of participating network centers treating patients with COVID-19, there were no relevant shortcomings reported regarding in-hospital stroke treatment or telemedical stroke care.
Conclusions
Telemedical stroke care in Germany was able to provide full service despite the COVID-19 pandemic, but telemedical consultations declined abruptly during the lockdown period and normalized after relaxation of COVID-19 measures in Germany.
Spinale Muskelatrophie (SMA), die häufigste autosomal rezessive neuromuskuläre Erkrankung bei Kindern und jungen Erwachsenen, wird durch Mutationen in der telomeren Kopie des survival motor neuron (SMN1) Gens auf dem humanen Chromosom 5 verursacht. Anders als bei Mäusen, welche nur ein Smn Gen haben, gibt es beim Menschen eine zweite Kopie (SMN2). Das Genprodukt dieser zweiten Kopie wird am C-Terminus bevorzugt alternativ gespleißt. Es bringt nur eine kleine Menge des vollständigen SMN Proteins hervor. Der Grund, warum eine reduzierte Menge des ubiquitär exprimierten SMN Proteins speziell zu einer Motorneuronendegeneration führt, ohne andere Zelltypen gleichermaßen zu betreffen ist noch immer nicht bekannt. Mit Hilfe der Yeast-Two-Hybrid Technik wurden die beiden heterogenen nukleären Ribonukleoproteine hnRNP-R und hnRNP-Q als neue SMN-bindende Proteine identifiziert. Diese beiden hochhomologen Proteine waren bereits bekannt und stehen in Verbindung mit dem RNA Metabolismus, im Speziellen: Editing, Transport und Spleißing. hnRNP-R und -Q interagieren mit Wildtyp Smn, aber nicht mit trunkierten oder mutierten Smn Formen, welche in SMA-Patienten gefunden wurden. Beide Proteine werden in den meisten Geweben exprimiert. Im Rückenmark von Mäusen ist die stärkste Expression am neunzehnten embryonalen Tag zu beobachten. Interessanterweise ist hnRNP-R hauptsächlich in den Axonen von Motoneuronen zu finden und kolokalisiert dort mit Smn. Im Mausmodell für die SMA konnte gezeigt werden, dass sich die Motoneurone von erkrankten Mäusen hinsichtlich der Morphologie ihrer Neuriten von solchen aus Wildtyp Mäusen unterscheiden. Werden hnRNP-R oder hnRNP-Q in kultivierten Nervenzellen exprimiert, so fördern sie das Wachstum von Neuriten. Bei SMA-Patienten ohne Mutation im SMN Gen konnte allerdings weder Mutation noch Deletion in hnRNP-R oder hnRNP-Q nachgewiesen werden. Die Ergebnisse dieser Arbeit können entscheidend zu einem besseren Verständnis der motoneuronen spezifischen Funktion von Smn bei der SMA beitragen.
Structural and functional modifications of synaptic connections (“synaptic plasticity”) are believed to mediate learning and memory processes. Thus, molecular mechanisms of how synapses assemble in both structural and functional terms are relevant for our understanding of neuronal development as well as the processes of learning and memory. Synapses form by an asymmetric association of highly specialized membrane domains: at the presynaptic active zone transmitter filled vesicles fuse, while transmitter receptors at the opposite postsynaptic density sense this signal. By genetic analysis, matrix proteins of active zones from various families have been shown to be important for fast vesicle fusion, and were suggested to contribute to synapse stability and assembly. The Sigrist lab in collaboration with the Buchner lab previously had shown that the large scaffold protein Bruchpilot (Brp) is essential for both the structural and functional integrity of active zones and for synaptic plasticity in Drosophila melanogaster. The work described in this thesis investigated several candidate proteins which appear to be involved in preand postsynaptic function, as summarized in the following: (1) DREP-2 (DEF45 related protein-2) had been found by co-immunoprecipitations with anti-Brp antibodies by Dr. Manuela Schmidt (unpublished data). Mutants and antibodies for the further study of DREP- 2 were generated in this thesis. Yeast two hybrid results suggest that DREP-2 might interact with dynein light chain 2, while in vivo imaging indicates that DREP-2 might be involved in bidirectional axonal transport. (2) Coimmunoprecipitation and pull down experiments suggested that the ARFGAP [ADP-ribosylation factor (ARF)-directed GTPase activating protein (GAP)] protein GIT (G-protein coupled receptor kinase interacting protein) could interact with the endocytosis associated molecule Stoned B (StnB). Mutants in the dgit gene showed an accumulation of large size vesicles, membrane intermediates and decreased vesicle density at the 3rd instar larval neuromuscular junction (NMJ) by electron microscopy (EM). The phenotypes accumulation of large size vesicles and membrane intermediates could be rescued partially by expression of Drosophila GIT (DGIT) or human GIT in dgit mutant background. Furthermore, by immunofluorescence the dgit mutant shows specifically decreased levels of StnB, which could be restored partially by the expression of DGIT. These results strongly support the suggestion that DGIT interacts with StnB, which is involved in the regulation of vesicle size, endocytosis or recycling of synaptic vesicles (SVs). Furthermore, the dgit mutants also showed signs of a mislocalization of the presynaptic protein Brp relative to the postsynaptic protein GluRIID, which could be rescued by expression of DGIT or human GIT in the dgit mutant background, but not by StnB. These results suggest that GIT on one hand executes roles in the regulation of synaptic vesicle endocytosis, but potentially also has structural roles for synapse assembly (3) Djm-1 is a candidate locus to mediate mental retardation in human patients when it is mutated. As a first step towards an understanding of the mechanistic role of DJM-1, Drosophila genetics were used to address DJM-1 function. So far, however, the djm-1 mutant generated in this thesis did not show a nervous system phenotype.